Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-05

FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Lupin Pharmaceuticals, expanding its approval for treating hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan potassium and hydrochlorothiazide (losartan potassium and hydrochlorothiazide)

Snippet

SUPPL AP for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)